ClinicalTrials.Veeva

Menu

Effect of Tumor Micronecrosis on Postoperative Transcatheter Arterial Chemoembolization in Patients With Hepatocellular Carcinomas

Zhejiang University logo

Zhejiang University

Status

Completed

Conditions

Carcinoma, Hepatocellular

Treatments

Procedure: transcatheter arterial chemoembolization

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Micronecrosis is a novel pathological feature of hepatocellular carcinoma (HCC). This study was aimed at evaluating the effect of tumor micronecrosis on postoperative transcatheter arterial chemoembolization (TACE) in patients with hepatocellular carcinomas, and further exploring the value of micronecrosis for guiding TACE in HCC management.

Enrollment

900 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • (1) pathologically confirmed HCC (2) achievement of R0 resection.

Exclusion criteria

  • (1) simultaneous presence of other tumors ; (2) receipt of preoperative anti-tumoral treatments; (3) concurrent treatment with other antitumoral therapies in combination with TACE; (4) tumor necrosis that could be observed by gross examination; (5) a lack of necessary preoperative laboratory test results.

Trial design

900 participants in 2 patient groups

micronecrosis(+) group
Treatment:
Procedure: transcatheter arterial chemoembolization
micronecrosis(-) group

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems